XML 43 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Business Acquisition - Summary of intangible assets acquired (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2023
USD ($)
Business Acquisition  
Impairment of intangible assets $ 4,600
Aceragen  
Business Acquisition  
Acquisition Date Fair Value 71,600
Aceragen | In-process research and development costs (IPR&D)  
Business Acquisition  
Acquisition Date Fair Value 71,600
Impairment of intangible assets (4,600)
Carrying Value 67,000
Aceragen | ACG-701 for Cystic Fibrosis  
Business Acquisition  
Acquisition Date Fair Value 50,700
Impairment of intangible assets (2,600)
Carrying Value 48,100
Aceragen | ACG-701 for Melioidosis  
Business Acquisition  
Acquisition Date Fair Value 14,900
Carrying Value 14,900
Aceragen | ACG-801 for Farber Disease  
Business Acquisition  
Acquisition Date Fair Value 6,000
Impairment of intangible assets (2,000)
Carrying Value $ 4,000